| Meta-analysis summary statistics for associations meeting genome-wide significance | |||||||
|---|---|---|---|---|---|---|---|
| Lead SNP | Biochemicals | EA/OA | Ntotal | EAF | Effect (SE) | Pmeta | Details |
| rs2694917 | glutamine / histidine | T/C | 7350 | 0.81 | 0.018 (0.002) | 1.64·10-29 | show |
| rs2657879 | gamma-glutamylglutamine | A/G | 7226 | 0.83 | 0.024 (0.003) | 5.85·10-19 | show |
| rs2657879 | glutamine | A/G | 7372 | 0.82 | 0.015 (0.002) | 6.15·10-18 | show |
EA = effect allele; OA = other allele; EAF = frequency of effect allele;
| Summary of biological annotations | |
|---|---|
| SNP | rs2694917 |
| Chromosomal location | Chr12: 55,199,131 (12q13.2) |
| Gene (distance) | GLS2 (30,684) |
| Predicted causal gene | GLS2 |
| Gene/protein classification | - |
| Metabolite (Pathway) | glutamine (Glutamate metabolism; Amino acid) histidine (Histidine metabolism; Amino acid) |
| Biochemical locus-metabolite relationship | GLS2 encodes the mitochondrial phosphate-activated glutaminase which catalyzes the hydrolysis of glutamine to glutamate and ammonia [10620514]. Ratio interpretation: GLS2 produces glutamine. Histidine may normalize for the amino acid pool ('normalizing'). |
| eQTL associations | GLS2 (L), GLS2 (S), RBMS2 (L), SPRYD4 (F), SPRYD4 (L), SPRYD4 (S) † |
† F = adipose tissue; S = skin cells; L = lymphoblastoid cells; H = liver cells;
| Medical information | |
|---|---|
| Complex trait associations | - |
| Known metabolite associations | Gln, Glc [22286219]; glutamine [21886157] (r2=0.782 with rs2657879) |
| Inborn error of metabolism | - |
| Pharmacological information | |
|---|---|
| ChEMBL ID | - |
| Drug information | - |
| Locus information for top associated metabolite | |
|---|---|
HapMap2 imputation![]() | 1KGP imputation![]() |








